PNC Financial Services Group
BIOA

PNC Financial Services Group’s BioAge Labs BIOA Stock Holding History

PNC Financial Services Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.4K Sell
1,974
-99
-5% -$1.79K ﹤0.01% 3365
2026
Q1 		$36.3K Sell
2,073
-110
-5% -$2.12K ﹤0.01% 3401
2025
Q4 		$28.9K Sell
2,183
-11
-0.5% -$98 ﹤0.01% 3491
2025
Q3 		$12.9K Buy
2,194
+1,855
+547% +$8.69K ﹤0.01% 3830
2025
Q2 		$1.4K Buy
+339
New +$1.37K ﹤0.01% 4503

Other funds holding BIOA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PNC Financial Services Group's BIOA Position: Q2 2026 in Review

PNC Financial Services Group reduced its BioAge Labs (BIOA) stake by 4.8% in Q2 2026, selling an estimated $1.79K and leaving 1,974 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3365.

PNC Financial Services Group first reported a position in BIOA in Q2 2025 and has held it in 5 quarters since. 43 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • PNC Financial Services Group held 1,974 shares of BioAge Labs worth $48.4K as of Q2 2026.
  • PNC Financial Services Group sold 99 BioAge Labs shares in Q2 2026, an estimated $1.79K.
  • BioAge Labs made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3365 holding.
  • PNC Financial Services Group first reported a position in BioAge Labs in Q2 2025 and has held it in 5 quarters since.
  • 43 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.